Erratum: Respiratory complications of organophosphorus nerve agent and insecticide poisoning. Implications for respiratory and critical care (American Journal of Respiratory and Critical Care Medicine DOI: 10.1164/rccm.201406-1150CI);Respiratory complications of organophosphorus nerve agent and insecticide poisoning: Implications for respiratory and critical care

American Journal of Respiratory and Critical Care Medicine

Volumn 190, Issue 12, 2014, Pages 1342-1354

  Hulse, Elspeth J ^a,b   Davies, James O J ^b,c   Simpson, A John ^d   Sciuto, Alfred M ^e   Eddleston, Michael ^a,b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF PERADENIYA   (Sri Lanka)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

^e US ARMY MEDICAL RESEARCH INSTITUTE OF CHEMICAL DEFENSE   (United States)

Author keywords

Critical care; Insecticide; Nerve agent; Organophosphorus

Indexed keywords

ADENOSINE; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ATROPINE; BENZODIAZEPINE DERIVATIVE; BICARBONATE; DIAZEPAM; GLUTAMATE RECEPTOR ANTAGONIST; GLYCOPYRRONIUM BROMIDE; HYDROLASE; MAGNESIUM; ORGANOPHOSPHATE INSECTICIDE; ORGANOPHOSPHORUS COMPOUND; OXIME; SOLVENT; CHEMICAL WARFARE AGENT; INSECTICIDE;

ACUTE RESPIRATORY FAILURE; ADULT RESPIRATORY DISTRESS SYNDROME; CAUSE OF DEATH; CLINICAL FEATURE; CONSCIOUSNESS DISORDER; HUMAN; INSECTICIDE POISONING; LUNG COMPLICATION; NONHUMAN; ORGANOPHOSPHATE POISONING; PNEUMONIA; RESPIRATORY FAILURE; REVIEW; WORLD HEALTH ORGANIZATION; INTENSIVE CARE; PROCEDURES; PULMONOLOGY;

CHEMICAL WARFARE AGENTS; CRITICAL CARE; HUMANS; INSECTICIDES; ORGANOPHOSPHATE POISONING; PULMONARY MEDICINE;

EID: 84919341240     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.v200erratum5     Document Type: Erratum

References (115)

1. WHO. Public health impact of pesticides used in agriculture. Geneva, Switzerland: World Health Organization; 1990.
2. Gunnell D, Eddleston M, Phillips MR, Konradsen F. The global distribution of fatal pesticide self-poisoning: Systematic review. BMC Public Health 2007;7: 357.
3. Patel V, Ramasundarahettige C, Vijayakumar L, Thakur JS, Gajalakshmi V, Gururaj G, Suraweera W, Jha P; Million Death Study Collaborators. Suicide mortality in India: A nationally representative survey. Lancet 2012;379: 2343-2351.
4. Eddleston M. Patterns and problems of deliberate self-poisoning in the developing world. QJM 2000;93: 715-731.
5. Sellestrom A, Cairns S, Barbeschi M. United nations mission to investigate allegations of the use of chemical weapons in the Syrian Arab Republic. Report on the alleged use of chemical weapons in the Ghouta area of Damascus on 21 August 2013. Geneva, Switzerland: United Nations; 2013.
6. Sidell F, Newmark J, McDonough J. Nerve agents. In: Lenhart M, editor. Medical aspects of chemical warfare. Washington, DC: Borden Institute, Walter Reed Army Medical Centre, Office of the Surgeon General, Department of the Army; 2008. pp. 155-220.
7. True B-L, Dreisbach RH. Cholinesterase inhibitor pesticides. In: True B.-L., Dreisbach RH, editors. Dreisbach's handbook of poisoning: Prevention, diagnosis and treatment, 13th ed. London, UK: Parthenon; 2001. pp. 123-132.
8. Lotti M. Clinical toxicology of anticholinesterase agents in humans. Handb Pesticide Toxicol 2001;2: 1043-1085.
9. Nachmansohn D, Feld EA. Studies on cholinesterase; on the mechanism of diisopropyl fluorophosphate action in vivo. J Biol Chem1947;171: 715-724.
10. Buckley NA, Eddleston M, Li Y, Bevan M, Robertson J. Oximes for acute organophosphate pesticide poisoning. Cochrane Database Syst Rev 2011: CD005085.
11. Casida JE, Quistad GB. Organophosphate toxicology: Safety aspects of nonacetylcholinesterase secondary targets. Chem Res Toxicol 2004;17: 983-998.
12. Duysen EG, Li B, Xie W, Schopfer LM, Anderson RS, Broomfield CA, Lockridge O. Evidence for nonacetylcholinesterase targets of organophosphorus nerve agent: Supersensitivity of acetylcholinesterase knockout mouse to VX lethality. J Pharmacol Exp Ther 2001;299: 528-535.
13. Dorandeu F, Mikler JR, Thiermann H, Tenn C, Davidson C, Sawyer TW, Lallement G, Worek F. Swine models in the design of more effective medical countermeasures against organophosphorus poisoning. Toxicology 2007;233: 128-144.
14. Okumura T, Takasu N, Ishimatsu S, Miyanoki S, Mitsuhashi A, Kumada K, Tanaka K, Hinohara S. Report on 640 victims of the Tokyo subway sarin attack. Ann Emerg Med 1996;28: 129-135.
15. Tsao TCY, Juang YC, Lan RS, Shieh WB, Lee CH. Respiratory failure of acute organophosphate and carbamate poisoning. Chest 1990;98: 631-636.
16. Sidell FR. Soman and sarin: Clinical manifestations and treatment of accidental poisoning by organophosphates. Clin Toxicol 1974;7: 1-17.
17. Lokan R, James R. Rapid death by mevinphos poisoning while under observation. Forensic Sci Int 1983;22: 179-182.
18. Eyer F, Meischner V, Kiderlen D, Thiermann H, Worek F, Haberkorn M, Felgenhauer N, Zilker T, Eyer P. Human parathion poisoning. A toxicokinetic analysis. Toxicol Rev 2003;22: 143-163.
19. Eddleston M, Mohamed F, Davies JOJ, Eyer P, Worek F, Sheriff MHR, Buckley NA. Respiratory failure in acute organophosphorus pesticide self-poisoning. QJM 2006;99: 513-522.
20. Eddleston M, Eyer P, Worek F, Mohamed F, Senarathna L, von Meyer L, Juszczak E, Hittarage A, Azhar S, Dissanayake W, et al. Differences between organophosphorus insecticides in human self-poisoning: A prospective cohort study. Lancet 2005;366: 1452-1459.
21. Senarathna L. How the level of resources and hospital staff attitude in primary care hospitals in rural Sri Lanka affect poisoning patient outcome. Centre for Clinical Epidemiology and Biostatistics. Newcastle, Australia: University of Newcastle; 2006. pp. 1-89.
22. Wadia RS, Sadagopan C, Amin RB, Sardesai HV. Neurological manifestations of organophosphorous insecticide poisoning. J Neurol Neurosurg Psychiatry 1974;37: 841-847.
23. Jayawardane P, Senanayake N, Buckley NA, Dawson AH. Electrophysiological correlates of respiratory failure in acute organophosphate poisoning: Evidence for differential roles of muscarinic and nicotinic stimulation. Clin Toxicol (Phila) 2012;50: 250-253.
24. Karalliedde L, Senanayake N. Organophosphorus insecticide poisoning. Br J Anaesth 1989;63: 736-750.
25. Karalliedde L. Organophosphorus poisoning and anaesthesia. Anaesthesia 1999;54: 1073-1088.
26. Rezk PE, Graham JR, Moran TS, Gordon RK, Sciuto AM, Doctor BP, Nambiar MP. Acute toxic effects of nerve agent VX on respiratory dynamics and functions following microinsillation inhalation exposure in guinea pigs. Inhal Toxicol 2007;19: 291-302.
27. Segura P, Chávez J, Montaño LM, Vargas MH, Delaunois A, Carbajal V, Gustin P. Identification of mechanisms involved in the acute airway toxicity induced by parathion. Naunyn Schmiedebergs Arch Pharmacol 1999;360: 699-710.
28. Wess J, Eglen RM, Gautam D. Muscarinic acetylcholine receptors: Mutant mice provide new insights for drug development. Nat Rev Drug Discov 2007;6: 721-733.
29. Kamat SR, Heera S, Potdar PV, Shah SV, Bhambure NM, Mahashur AA. Bombay experience in intensive respiratory care over 6 years. J Postgrad Med 1989;35: 123-134.
30. Kummer W, Lips KS, Pfeil U. The epithelial cholinergic system of the airways. Histochem Cell Biol 2008;130: 219-234.
31. Takemura Y, Helms MN, Eaton AF, Self J, Ramosevac S, Jain L, Bao H-F, Eaton DC. Cholinergic regulation of epithelial sodium channels in rat alveolar type 2 epithelial cells. Am J Physiol Lung Cell Mol Physiol 2013;304: L428-L437.
32. Matthay MA, Folkesson HG, Clerici C. Lung epithelial fluid transport and the resolution of pulmonary edema. Physiol Rev 2002;82: 569-600.
33. Carey JL, Dunn C, Gaspari RJ. Central respiratory failure during acute organophosphate poisoning. Respir Physiol Neurobiol 2013;189: 403-410.
34. Ware LB, Matthay MA. Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med 2001;163: 1376-1383.
35. Lainee P, Robineau P, Guittin P, Coq H, Benchetrit G. Mechanisms of pulmonary edema induced by an organophosphorus compound in anesthetized dogs. Fundam Appl Toxicol 1991;17: 177-185.
36. Delaunois A, Gustin P, Ansay M. Multiple muscarinic receptor subtypes mediating pulmonary oedema in the rabbit. Pulm Pharmacol 1994;7: 185-193.
37. Yavuz Y, Kaya E, Yurumez Y, Sahin O, Bas O, Fidan H, Sezer M. Technetium-99m diethylenetriaminepentaacetic acid radioaerosol scintigraphy in organophosphate induced pulmonary toxicity: Experimental study. Clin Toxicol (Phila) 2008;46: 711-715.
38. Hulse E, Reed FC, Eddleston M, Etherington R, Clutton RE. A model describing the use of a bronchial blocking device and a sheathed bronchoscope for pulmonary aspiration studies in the Gottingen minipig. Lab Anim 2014;48: 164-169.
39. Akgur S, Veral A, Ege B. Adult respiratory distress syndrome in human organophosphate poisoning cases. Toxicol Environ Chem 2008;90: 493-499.
40. Ferguson ND, Frutos-Vivar F, Esteban A, Fernández-Segoviano P, Aramburu JA, Nájera L, Stewart TE. Acute respiratory distress syndrome: Underrecognition by clinicians and diagnostic accuracy of three clinical definitions. Crit Care Med 2005;33: 2228-2234.
41. Wright BS, Rezk PE, Graham JR, Steele KE, Gordon RK, Sciuto AM, Nambiar MP. Acute lung injury following inhalation exposure to nerve agent VX in guinea pigs. Inhal Toxicol 2006;18: 437-448.
42. Perkins MW, Wong B, Rodriguez A, Devorak JL, Alves DA, Murphy G, Sciuto AM. Inhalation toxicity of soman vapor in non-Anesthetized rats: A preliminary assessment of inhaled bronchodilator or steroid therapy. Chem Biol Interact 2013;206: 452-461.
43. Gundavarapu S, Zhuang J, Barrett EG, Xu F, Russell RG, Sopori ML. A critical role of acute bronchoconstriction in the mortality associated with high-dose sarin inhalation: Effects of epinephrine and oxygen therapies. Toxicol Appl Pharmacol 2014;274: 200-208.
44. Anzueto A, deLemos RA, Seidenfeld J, Moore G, Hamil H, Johnson D, Jenkinson SG. Acute inhalation toxicity of soman and sarin in baboons. Fundam Appl Toxicol 1990;14: 676-687.
45. De Candole CA, Douglas WW, Evans CL, Holmes R, Spencer KEV, Torrance RW, Wilson KM. The failure of respiration in death by anticholinesterase poisoning. Br Pharmacol Chemother 1953;8: 466-475.
46. Singh G, Sidhu UPS, Mahajan R, Avasthi G, Whig J. Phrenic nerve conduction studies in acute organophosphate poisoning. Muscle Nerve 2000;23: 627-632.
47. Gaspari RJ, Paydarfar D. Dichlorvos-induced central apnea: Effects of selective brainstem exposure in the rat. Neurotoxicology 2011;32: 206-214.
48. Burchfiel JL, Duffy FH. Organophosphate neurotoxicity: Chronic effects of sarin on the electroencephalogram of monkey and man. Neurobehav Toxicol Teratol 1982;4: 767-778.
49. Bird SB, Gaspari RJ, Dickson EW. Early death due to severe organophosphate poisoning is a centrally mediated process. Acad Emerg Med 2003;10: 295-298.
50. Dickson EW, Bird SB, Gaspari RJ, Boyer EW, Ferris CF. Diazepam inhibits organophosphate-induced central respiratory depression. Acad Emerg Med 2003;10: 1303-1306.
51. Banks CN, Lein PJ. A review of experimental evidence linking neurotoxic organophosphorus compounds and inflammation. Neurotoxicology 2012;33: 575-584.
52. John M, Oommen A, Zachariah A. Muscle injury in organophosphorous poisoning and its role in the development of intermediate syndrome. Neurotoxicology 2003;24: 43-53.
53. Hrabetz H, Thiermann H, Felgenhauer N, Zilker T, Haller B, Nährig J, Saugel B, Eyer F. Organophosphate poisoning in the developed world -A single centre experience from here to the millennium. Chem Biol Interact 2013;206: 561-568.
54. Eddleston M, Haggalla S, Reginald K, Sudarshan K, Senthilkumaran M, Karalliedde L, Ariaratnam A, Sheriff MHR, Warrell DA, Buckley NA. The hazards of gastric lavage for intentional selfpoisoning in a resource poor location. Clin Toxicol (Phila) 2007; 45: 136-143.
55. Isbister GK, Downes F, Sibbritt D, Dawson AH, Whyte IM. Aspiration pneumonitis in an overdose population: Frequency, predictors, and outcomes. Crit Care Med 2004;32: 88-93.
56. Schubert ML, Peura DA. Control of gastric acid secretion in health and disease. Gastroenterology 2008;134: 1842-1860.
57. Aihara T, Nakamura Y, Taketo MM, Matsui M, Okabe S. Cholinergically stimulated gastric acid secretion is mediated by M(3) and M(5) but not M(1) muscarinic acetylcholine receptors in mice. Am J Physiol Gastrointest Liver Physiol 2005;288: G1199-G1207.
58. Marik PE. Aspiration pneumonitis and aspiration pneumonia. N Engl J Med 2001;344: 665-671.
59. Brégeon F, Papazian L, Delpierre S, Kajikawa O, Payan M-J, Martin TR, Kipson N, Pugin J. Role of proinflammatory activity contained in gastric juice from intensive care unit patients to induce lung injury in a rabbit aspiration model. Crit Care Med 2008;36: 3205-3212.
60. Meade MO, Cook DJ, Guyatt GH, Slutsky AS, Arabi YM, Cooper DJ, Davies AR, Hand LE, Zhou Q, Thabane L, et al.; Lung Open Ventilation Study Investigators. Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive endexpiratory pressure for acute lung injury and acute respiratory distress syndrome: A randomized controlled trial. JAMA 2008; 299: 637-645.
61. Matthay MA, Rosen GD. Acid aspiration induced lung injury. New insights and therapeutic options. Am J Respir Crit Care Med 1996; 154: 277-278.
62. Chawla R. Epidemiology, etiology, and diagnosis of hospital-Acquired pneumonia and ventilator-Associated pneumonia in Asian countries. Am J Infect Control 2008; 36(4, Suppl)S93-S100.
63. Slutsky AS, Ranieri VM. Ventilator-induced lung injury. N Engl J Med 2013;369: 2126-2136.
64. Hunter JD. Ventilator associated pneumonia. BMJ 2012;344: E3325.
65. Walsh TS, Morris AC, Simpson AJ. Ventilator associated pneumonia: Can we ensure that a quality indicator does not become a game of chance? Br J Anaesth 2013;111: 333-337.
66. Price R, MacLennan G, Glen J; SuDDICU Collaboration. Selective digestive or oropharyngeal decontamination and topical oropharyngeal chlorhexidine for prevention of death in general intensive care: Systematic review and network meta-Analysis. BMJ 2014;348: G2197.
67. Tracey KJ. Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest 2007;117: 289-296.
68. Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, Li JH, Wang H, Yang H, Ulloa L, et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 2003; 421: 384-388.
69. Giebelen IAJ, Leendertse M, Florquin S, van der Poll T. Stimulation of acetylcholine receptors impairs host defence during pneumococcal pneumonia. Eur Respir J 2009;33: 375-381.
70. Xu M, Scott JE, Liu K-Z, Bishop HR, Renaud DE, Palmer RM, Soussi-Gounni A, Scott DA. The influence of nicotine on granulocytic differentiation -inhibition of the oxidative burst and bacterial killing and increased matrix metalloproteinase-9 release. BMC Cell Biol 2008;9: 19.
71. Zabrodskii PF, Grishin VA, Borodavko VK. Mechanism of suppression of phagocytic and metabolic activity of neutrophils and production of proinflammatory cytokines during chronic poisoning with organophosphorus compounds. Bull Exp Biol Med 2013;155: 464-466.
72. Gwilt CR, Donnelly LE, Rogers DF. The non-neuronal cholinergic system in the airways: An unappreciated regulatory role in pulmonary inflammation? Pharmacol Ther 2007;115: 208-222.
73. Hermanowicz A, Kossman S. Neutrophil function and infectious disease in workers occupationally exposed to phosphoorganic pesticides: Role of mononuclear-derived chemotactic factor for neutrophils. Clin Immunol Immunopathol 1984;33: 13-22.
74. Senanayake N, Karalliedde L. Neurotoxic effects of organophosphorus insecticides. An intermediate syndrome. N Engl J Med 1987;316: 761-763.
75. Indira M, Andrews MA, Rakesh TP. Incidence, predictors, and outcome of intermediate syndrome in cholinergic insecticide poisoning: A prospective observational cohort study. Clin Toxicol (Phila) 2013; 51: 838-845.
76. De Bleecker J, Van den Neucker K, Colardyn F. Intermediate syndrome in organophosphorus poisoning: A prospective study. Crit Care Med 1993;21: 1706-1711.
77. Jayawardane P, Dawson AH, Weerasinghe V, Karalliedde L, Buckley NA, Senanayake N. The spectrum of intermediate syndrome following acute organophosphate poisoning: A prospective cohort study from Sri Lanka. PLoS Med 2008;5: 1143-1153.
78. Sidell FR, Hurst CG. Chapter 8: Long-term health effects of nerve agents and mustard. In: Sidell FR, Takafuji ET, Franz DR, editors. Medical aspects of chemical and biological warfare. Washington, DC: U.S. Government Printing; 1997. pp. 229-246.
79. Morita H, Yanagisawa N, Nakajima T, Shimizu M, Hirabayashi H, Okudera H, Nohara M, Midorikawa Y, Mimura S. Sarin poisoning in Matsumoto, Japan. Lancet 1995;346: 290-293.
80. Khan S, Hemalatha R, Jeyaseelan L, Oommen A, Zachariah A. Neuroparalysis and oxime efficacy in organophosphate poisoning: A study of butyrylcholinesterase. Hum Exp Toxicol 2001;20: 169-174.
81. Eddleston M, Street JM, Self I, Thompson A, King T, Williams N, Naredo G, Dissanayake K, Yu L-M, Worek F, et al. A role for solvents in the toxicity of agricultural organophosphorus pesticides. Toxicology 2012;294: 94-103.
82. De Reuck J, Willems J. Acute parathion poisoning: Myopathic changes in the diaphragm. J Neurol 1975;208: 309-313.
83. Davies JE, Barquet A, Freed VH, Haque R, Morgade C, Sonneborn RE, Vaclavek C. Human pesticide poisonings by a fat-soluble organophosphate insecticide. Arch Environ Health 1975;30: 608-613.
84. Peter JV, Prabhakar AT, Pichamuthu K. Delayed-onset encephalopathy and coma in acute organophosphate poisoning in humans. Neurotoxicology 2008;29: 335-342.
85. Glynn P. A mechanism for organophosphate-induced delayed neuropathy. Toxicol Lett 2006;162: 94-97.
86. Richardson RJ, Hein ND, Wijeyesakere SJ, Fink JK, Makhaeva GF. Neuropathy target esterase (NTE): Overview and future. Chem Biol Interact 2013;203: 238-244.
87. Rivett K, Potgieter PD. Diaphragmatic paralysis after organophosphate poisoning. A case report. S Afr Med J 1987;72: 881-882.
88. Yanagisawa N, Morita H, Nakajima T. Sarin experiences in Japan: Acute toxicity and long-term effects. J Neurol Sci 2006; 249: 76-85.
89. Ghanei M, Naderi M, Kosar AM, Harandi AA, Hopkinson NS, Poursaleh Z. Long-term pulmonary complications of chemical warfare agent exposure in Iraqi Kurdish civilians. Inhal Toxicol 2010;22: 719-724.
90. NoguéS, Sanz P, Borondo JC, Picón M, de la Red G, Mestre G. Fatal lipoid pneumonia due to bronco-Aspiration of isoparaffin after ingestion of an organophosphate insecticide. Acta Anaesthesiol Scand 2003;47: 777-779.
91. Eddleston M, Dawson A, Karalliedde L, Dissanayake W, Hittarage A, Azher S, Buckley NA. Early management after self-poisoning with an organophosphorus or carbamate pesticide -A treatment protocol for junior doctors. Crit Care 2004;8: R391-R397.
92. Konickx LA, Bingham K, Eddleston M. Is oxygen required before atropine administration in organophosphorus or carbamate pesticide poisoning? -A cohort study. Clin Toxicol (Phila) 2014;52: 531-537.
93. Eddleston M, Buckley NA, Checketts H, Senarathna L, Mohamed F, Sheriff MHR, Dawson A. Speed of initial atropinisation in significant organophosphorus pesticide poisoning-A systematic comparison of recommended regimens. J Toxicol Clin Toxicol 2004;42: 865-875.
94. Abedin MJ, Sayeed AA, Basher A, Maude RJ, Hoque G, Faiz MA. Open-label randomized clinical trial of atropine bolus injection versus incremental boluses plus infusion for organophosphate poisoning in Bangladesh. J Med Toxicol 2012;8: 108-117.
95. Thiermann H, Worek F, Kehe K. Limitations and challenges in treatment of acute chemical warfare agent poisoning. Chem Biol Interact 2013; 206: 435-443.
96. MacIntyre NR, Cook DJ, Ely EW Jr, Epstein SK, Fink JB, Heffner JE, Hess D, Hubmayer RD, Scheinhorn DJ; American College of Chest Physicians; American Association for Respiratory Care; American College of Critical Care Medicine. Evidence-based guidelines for weaning and discontinuing ventilatory support: A collective task force facilitated by the American College of Chest Physicians; the American Association for Respiratory Care; and the American College of Critical Care Medicine. Chest 2001; 120(6, Suppl)375S-395S.
97. Worek F, Thiermann H, Szinicz L, Eyer P. Kinetic analysis of interactions between human acetylcholinesterase, structurally different organophosphorus compounds and oximes. Biochem Pharmacol 2004;68: 2237-2248.
98. Pawar KS, Bhoite RR, Pillay CP, Chavan SC, Malshikare DS, Garad SG. Continuous pralidoxime infusion versus repeated bolus injection to treat organophosphorus pesticide poisoning: A randomised controlled trial. Lancet 2006;368: 2136-2141.
99. Namba T, Nolte CT, Jackrel J, Grob D. Poisoning due to organophosphate insecticides. Acute and chronic manifestations. Am J Med 1971;50: 475-492.
100. Grob D. The manifestations and treatment of poisoning due to nerve gas and other organic phosphate anticholinesterase compounds. AMA Arch Intern Med 1956;98: 221-239.
101. Bardin PG, Van Eeden SF. Organophosphate poisoning: Grading the severity and comparing treatment between atropine and glycopyrrolate. Crit Care Med 1990;18: 956-960.
102. Elsinghorst PW, Worek F, Thiermann H, Wille T. Drug development for the management of organophosphorus poisoning. Expert Opin Drug Discov 2013;8: 1467-1477.
103. Sheridan RD, Smith AP, Turner SR, Tattersall JE. Nicotinic antagonists in the treatment of nerve agent intoxication. J R Soc Med 2005;98: 114-115.
104. Rosenberg YJ, Laube B, Mao L, Jiang X, Hernandez-Abanto S, Lee KD, Adams R. Pulmonary delivery of an aerosolized recombinant human butyrylcholinesterase pretreatment protects against aerosolized paraoxon in macaques. Chem Biol Interact 2013;203: 167-171.
105. Pichamuthu K, Jerobin J, Nair A, John G, Kamalesh J, Thomas K, Jose A, Fleming JJ, Zachariah A, David SS, et al. Bioscavenger therapy for organophosphate poisoning -An open-labeled pilot randomized trial comparing fresh frozen plasma or albumin with saline in acute organophosphate poisoning in humans. Clin Toxicol (Phila) 2010;48: 813-819.
106. Pazooki S, Solhi H, Vishteh HR, Shadnia S, Beigi MJ. Effectiveness of fresh frozen plasma as supplementary treatment in organophosphate poisoning. Med J Malaysia 2011;66: 342-345.
107. Buckley NA, Eddleston M, Dawson AH. The need for translational research on antidotes for pesticide poisoning. Clin Exp Pharmacol Physiol 2005;32: 999-1005.
108. Peter JV, Moran JL, Pichamuthu K, Chacko B. Adjuncts and alternatives to oxime therapy in organophosphate poisoning-is there evidence of benefit in human poisoning? A review. Anaesth Intensive Care 2008;36: 339-350.
109. Dunn C, Bird SB, Gaspari R. Intralipid fat emulsion decreases respiratory failure in a rat model of parathion exposure. Acad Emerg Med 2012;19: 504-509.
110. Gupta RD, Goldsmith M, Ashani Y, Simo Y, Mullokandov G, Bar H, Ben-David M, Leader H, Margalit R, Silman I, et al. Directed evolution of hydrolases for prevention of G-type nerve agent intoxication. Nat Chem Biol 2011;7: 120-125.
111. Basher A, Rahman SH, Ghose A, Arif SM, Faiz MA, Dawson AH. Phase II study of magnesium sulfate in acute organophosphate pesticide poisoning. Clin Toxicol (Phila) 2013;51: 35-40.
112. Fleming NW, Macres S, Antognini JF, Vengco J. Neuromuscular blocking action of suxamethonium after antagonism of vecuronium by edrophonium, pyridostigmine or neostigmine. Br J Anaesth 1996;77: 492-495.
113. Sener EB, Ustun E, Kocamanoglu S, Tur A. Prolonged apnea following succinylcholine administration in undiagnosed acute organophosphate poisoning. Acta Anaesthesiol Scand 2002;46: 1046-1048.
114. Baruah J, Easby J, Kessell G. Effects of acetylcholinesterase inhibitor therapy for Alzheimer's disease on neuromuscular block. Br J Anaesth 2008;100: 420.
115. Erickson SE, Martin GS, Davis JL, Matthay MA, Eisner MD, NIH NHLBI ARDS Network. Recent trends in acute lung injury mortality: 1996-2005. Crit Care Med 2009;37: 1574-1579.